Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIEW-1201 vs ofloxacin for acute bacterial conjunctivitis (Phase II, China)
CTR20223272Phase 2Completed
- Sponsor
- IVIEW Therapeutics Inc.
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of povidone-iodine in bacterial conjunctivitis (BC), sponsored by IVIEW Therapeutics Inc.. Started Dec 2022; status: completed.
02
Drugs
povidone-iodine
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on CTR20223272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223272.